Do DNOW’s (DNOW) ERP Disclosure Questions Undercut Its Acquisition and Digital Transformation Story?

• In May 2026, DNOW Inc. held its Annual Meeting of Stockholders, re-electing nine directors, ratifying KPMG LLP as auditor for 2026, and securing advisory approval of executive compensation while directors received routine equity awards as part of their pay.
• At the same time, shareholder law firms began investigating DNOW over alleged misleading disclosures tied to persistent ERP implementation problems at acquisition target MRC Global, raising fresh governance and disclosure-risk questions for investors.
• Next, we’ll examine how these ERP-related disclosure concerns may affect DNOW’s previously bullish investment narrative built around acquisitions and digital initiatives.

We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

DNOW Investment Narrative Recap

To own DNOW today, you need to believe that acquisitions like MRC Global and DNOW’s digital initiatives can eventually translate into profitable growth despite current integration pain. The most important short term catalyst is progress on fixing MRC’s ERP issues, while the biggest risk is that ongoing disruption and any misleading-disclosure claims prolong operational weakness. The recent shareholder investigations and stock drop make that risk feel more immediate rather than introducing a new one.

The May 2026 Annual Meeting results, including re election of all nine directors and advisory approval of executive pay, matter here because they show formal shareholder support for the current board overseeing the MRC integration. At the same time, routine equity awards to directors sit uncomfortably beside fresh questions around ERP disclosures and governance quality, which could influence how investors weigh DNOW’s acquisition and digital catalysts against execution and legal risks.

Yet behind DNOW’s acquisition and digital story, investors should be aware of how unresolved ERP problems at MRC and related disclosure questions could...

Read the full narrative on DNOW (it's free!)

DNOW's narrative projects $5.2 billion revenue and $223.8 million earnings by 2029. This requires 22.9% yearly revenue growth and a $312.8 million earnings increase from -$89.0 million today.

Uncover how DNOW's forecasts yield a $16.00 fair value, a 22% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community valuations cluster between US$16.00 and about US$19.18 per share, underlining how far opinions can spread. You should weigh these against the very real execution risk around MRC’s troubled ERP rollout and what that might mean for DNOW’s ability to turn its acquisition driven growth story into sustainable profitability over time.

Explore 3 other fair value estimates on DNOW - why the stock might be worth just $16.00!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DNOW research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free DNOW research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DNOW's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 13 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 49 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com